Clinical Trials Logo
  1. Home
  2. Gynecological Malignancies
  3. NCT02718209

The Development of an In-vitro System to Identify Gynecologic Cancer Cells During Surgical Procedures

Gynecological Malignancies Clinical Trial

Clinical Trial Summary

The purpose of this study is to examine the efficacy of mid-infrared spectroscopy together with Attenuated Total Reflection (ATR), for the detection of gynecological malignancies in real time during surgery.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02718209
Study type Interventional
Source Hillel Yaffe Medical Center
Contact Ilan Bruchim, MD
Email ilanb@hy.health.gov.il
Status Not yet recruiting
Phase N/A
Start date April 2016
Completion date April 2018
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05914974 - Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
Completed NCT00121030 - Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy Phase 2
Completed NCT00770536 - AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR Phase 1
Recruiting NCT06131450 - A Study of BL-M07D1 in Patients With HER2-expressing Recurrent or Metastatic Gynecologic Malignancies Phase 1/Phase 2
Recruiting NCT06151028 - An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy
Recruiting NCT04905329 - A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations